196 related articles for article (PubMed ID: 8760976)
1. Characterisation of angiotensin II receptor mediated responses and inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor, L158,809.
Davies MG; Fulton GJ; Barber L; Dalen H; Svendsen E; Hagen PO
Eur J Vasc Endovasc Surg; 1996 Aug; 12(2):151-61. PubMed ID: 8760976
[TBL] [Abstract][Full Text] [Related]
2. Localized versus systemic angiotensin II receptor inhibition of intimal hyperplasia in experimental vein grafts by the specific angiotensin II receptor inhibitor L158,809.
Fulton GJ; Davies MG; Barber L; Svendsen E; Hagen PO
Surgery; 1998 Feb; 123(2):218-27. PubMed ID: 9481409
[TBL] [Abstract][Full Text] [Related]
3. Lazaroid therapy (methylaminochroman: U83836E) reduces vein graft intimal hyperplasia.
Davies MG; Dalen H; Barber L; Svendsen E; Hagen PO
J Surg Res; 1996 Jun; 63(1):128-36. PubMed ID: 8661185
[TBL] [Abstract][Full Text] [Related]
4. Oral monoterpene therapy (perillyl alcohol) reduces vein graft intimal hyperplasia.
Fulton GJ; Barber L; Svendsen E; Hagen PO; Davies MG
J Surg Res; 1997 Apr; 69(1):128-34. PubMed ID: 9202658
[TBL] [Abstract][Full Text] [Related]
5. Control of the structural and functional consequences of vein graft intimal hyperplasia with a 21-aminosteroid--U74389G.
Davies MG; Barber L; Dalen H; Svendsen E; Hagen PO
Eur J Vasc Surg; 1994 Jul; 8(4):448-56. PubMed ID: 8088396
[TBL] [Abstract][Full Text] [Related]
6. Ramipril and experimental vein graft intimal hyperplasia.
Davies MG; Klyachkin ML; Barber L; Svendsen E; Hagen PO
Angiology; 1995 Feb; 46(2):91-7. PubMed ID: 7702205
[TBL] [Abstract][Full Text] [Related]
7. Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine.
Davies MG; Kim JH; Dalen H; Makhoul RG; Svendsen E; Hagen PO
Surgery; 1994 Sep; 116(3):557-68. PubMed ID: 8079186
[TBL] [Abstract][Full Text] [Related]
8. Time course of the regression of intimal hyperplasia in experimental vein grafts.
Davies MG; Fulton GJ; Svendsen E; Hagen PO
Cardiovasc Pathol; 1999; 8(3):161-8. PubMed ID: 10722239
[TBL] [Abstract][Full Text] [Related]
9. Reduction of intimal hyperplasia and enhanced reactivity of experimental vein bypass grafts with verapamil treatment.
el-Sanadiki MN; Cross KS; Murray JJ; Schuman RW; Mikat E; McCann RL; Hagen PO
Ann Surg; 1990 Jul; 212(1):87-96. PubMed ID: 2363608
[TBL] [Abstract][Full Text] [Related]
10. Local effects of nitric oxide supplementation and suppression in the development of intimal hyperplasia in experimental vein grafts.
Fulton GJ; Davies MG; Barber L; Gray JL; Svendsen E; Hagen PO
Eur J Vasc Endovasc Surg; 1998 Apr; 15(4):279-89. PubMed ID: 9610339
[TBL] [Abstract][Full Text] [Related]
11. Suppression of intimal hyperplasia in experimental vein grafts by oral l-arginine supplementation and single ex vivo immersion in deferoxamine manganese.
Davis MG; Dalen H; Austerheim AM; Gulbrandsen TF; Svendsen E; Hagen PO
J Vasc Surg; 1996 Mar; 23(3):410-20. PubMed ID: 8601882
[TBL] [Abstract][Full Text] [Related]
12. The temporal sequence of G-protein expression in intimal hyperplasia.
Davies MG; Barber L; Dhanraj DN; Gettys TW; Ramkumar V; Hagen PO
J Surg Res; 1996 Jun; 63(1):115-22. PubMed ID: 8661183
[TBL] [Abstract][Full Text] [Related]
13. Antisense oligonucleotide to proto-oncogene c-myb inhibits the formation of intimal hyperplasia in experimental vein grafts.
Fulton GJ; Davies MG; Koch WJ; Dalen H; Svendsen E; Hagen PO
J Vasc Surg; 1997 Mar; 25(3):453-63. PubMed ID: 9081126
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of altered angiotensin II responses in experimental vein grafts.
Davies MG; Hagen PO
J Invest Surg; 1996; 9(6):423-32. PubMed ID: 8981215
[TBL] [Abstract][Full Text] [Related]
15. Postoperative reduction of high serum cholesterol concentrations and experimental vein bypass grafts. Effect on the development of intimal hyperplasia and abnormal vasomotor function.
Klyachkin ML; Davies MG; Kim JH; Barber L; Dalen H; Svendsen E; Hagen PO
J Thorac Cardiovasc Surg; 1994 Sep; 108(3):556-66. PubMed ID: 8078349
[TBL] [Abstract][Full Text] [Related]
16. Characterization of dopamine-mediated relaxation in experimental vein bypass grafts.
Davies MG; Huynh TT; Hagen PO
J Surg Res; 2000 Jul; 92(1):103-7. PubMed ID: 10864489
[TBL] [Abstract][Full Text] [Related]
17. Local inhibition of tyrosine kinase activity markedly attenuates the development of intimal hyperplasia in experimental vein grafts.
Huynh TT; Davies MG; Barber L; Svendsen E; Hagen PO
J Surg Res; 1998 Jul; 77(2):104-11. PubMed ID: 9733595
[TBL] [Abstract][Full Text] [Related]
18. Chronic ACE inhibition reduces intimal hyperplasia in experimental vein grafts.
O'Donohoe MK; Schwartz LB; Radic ZS; Mikat EM; McCann RL; Hagen PO
Ann Surg; 1991 Dec; 214(6):727-32. PubMed ID: 1741654
[TBL] [Abstract][Full Text] [Related]
19. Hydrophilic statin suppresses vein graft intimal hyperplasia via endothelial cell-tropic Rho-kinase inhibition.
Yamanouchi D; Banno H; Nakayama M; Sugimoto M; Fujita H; Kobayashi M; Kuwano H; Komori K
J Vasc Surg; 2005 Oct; 42(4):757-64. PubMed ID: 16242565
[TBL] [Abstract][Full Text] [Related]
20. Perivenous application of cyanoacrylate tissue sealants reduces intimal and medial thickening of the vein graft and inflammatory responses in a rabbit model of carotid artery bypass grafting.
Dai L; Gao M; Gu C; Zhang F; Yu Y
Eur J Cardiothorac Surg; 2016 Feb; 49(2):675-81. PubMed ID: 25838460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
